Stanley Xie
Stanley advises investment banks and corporate clients on capital markets transactions across Asia Pacific, and also leads our Beijing office.
Stanley has extensive experience of advising investment banks and corporations on a range of PRC related corporate finance transactions, including equity capital market transactions, debt capital market transactions, and other cross-border transactions.
He advises broadly on initial public offerings, private placements and rights issues, as well as investment grade, high yield and sovereign debt offerings under Rule 144A and Regulation S.
Stanley's practice covers a broad range of industries, including healthcare, TMT, consumer products, financial services, education, energy and natural resources, and real estate.
Background
Stanley is admitted to practice in the PRC and New York, USA. He obtained master's degrees in law from the East China University of Political Science and Law in China and from the University of Michigan Law School in the United States.
Stanley is a native Mandarin speaker and is fluent in English and Cantonese.
Experience & expertise
Selected matters
- CITIC Securities (Hong Kong) Limited as the sole sponsor and CLSA Limited, China International Capital Corporation Hong Kong Securities Limited, Jefferies Hong Kong Limited, Deutsche Bank AG, Hong Kong Branch and CMB International Capital Limited as the overall coordinators of QuantumPharm Inc.'s listing on the Main Board of the Hong Kong Stock Exchange. QuantumPharm was the first listing under Chapter 18C, a new regime introduced by the Hong Kong Stock Exchange in March 2023 for specialist technology companies
- Huatai Financial Holdings (Hong Kong) Limited and BOCI Asia Limited as joint sponsors of Tian Tu Capital Co., Ltd.'s listing on the Main Board of the Hong Kong Stock Exchange
- China International Capital Corporation as the sole sponsor of LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.'s listing on the Main Board of the Hong Kong Stock Exchange
- CITIC Securities, Citigroup and Goldman Sachs as joint sponsors of Onewo Inc. HK$5.6 billion's listing on the Main Board of the Hong Kong Stock Exchange
- China Huaneng Group Co., Ltd on its US$500 million 5.30% subordinated guaranteed perpetual bonds issue, the first US dollar-denominated perpetual bond in 2024 issued by a Chinese state-owned company since 2022
Sectors
